Project Grant R35GM162089
- Federal Project Grant Award Summary The University of Washington received a $427,625 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2030. This award supports research and development of a novel nano-prodrug delivery platform designed to target microbiome-modulating molecules to the distal gastrointestinal tract. The research integrates...
- Federal Project Grant Award Summary The University of Washington's Office of Sponsored Programs received a $427,625 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, with completion targeted for August 31, 2030. This grant supports the development of capillaric microfluidics technology designed to enable integrated, self-powered, and self-regulated sample...
- Federal Project Grant Award Summary Fred Hutchinson Cancer Center received a $129,708 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) for the period August 1, 2025 through July 31, 2026. The award supports the development of computational tools and methodologies for analyzing single-cell molecular data to advance understanding of cellular differentiation and cancer progression. Specifically, the...
- Federal Grant Award Summary The University of Washington received a $125,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2027. This award funds fundamental research investigating the molecular coordination between two critical second messenger signaling pathways—cyclic diguanylate monophosphate (c-di-GMP) and cyclic adenosine...
- Federal Grant Award Summary The National Human Genome Research Institute (NHGRI) awarded the University of Washington a $2.22 million Project Grant on September 10, 2025, under the Human Genome Research program (CFDA 93.172) to develop sequence-to-function (S2F) deep learning models for mechanistic investigations of personal genomes. The research addresses two critical limitations in current S2F models: their inability to accurately predict subtle gene expression consequences arising from...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $363,570 Project Grant to the University of California, Los Angeles (UCLA) effective March 15, 2026, through February 28, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This award funds the development of integrative computational and analytical methods to reconstruct three-dimensional (3D) genome structures from single cells by combining imaging data with...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Johns Hopkins University a $426,479 Project Grant, effective September 1, 2025 through August 31, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports the development of statistical and computational methods to synthesize large-scale genomic and clinical data from biobanks, electronic health records, and clinical registries for precision risk...
- Federal Grant Award Summary The University of Michigan has received a $424,264 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2025 through May 31, 2030. This award supports the development of advanced quantitative analysis methodologies for long-read RNA-sequencing (RNA-seq) data at both bulk and single-cell dimensions. The research will advance understanding of gene...
- Federal Project Grant Award Summary The University of California, San Diego received a $327,019 Project Grant award dated July 25, 2025, from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research through April 30, 2030, focusing on developing innovative biophysical and computational frameworks to understand how cells transform during embryogenesis and stem cell differentiation. The...
- Federal Grant Award Summary New York University received a $333,076 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 8, 2025, with a completion date of July 31, 2029. The grant funds the development of novel statistical methods, algorithms, and computational pipelines designed to identify and characterize disease subgroups within high-dimensional omics data, including genomic,...
The University of Washington received a $380,371 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026 through February 28, 2031. This award supports the development of computational methods to infer cellular history from single-cell sequencing data, enabling researchers to reconstruct disease progression in tissues that are not longitudinally accessible, such as the brain in Alzheimer's disease or the heart in cardiomyopathy studies. The research employs a three-pronged approach: leveraging lineage-tracing single-cell RNA sequencing to quantify cellular history inference capacity, analyzing single-cell RNA sequencing data from large donor cohorts to decode human-specific disease dynamics while accounting for biological and environmental variability, and integrating single-cell multi-omics techniques to model regulatory mechanisms driving cellular transitions over time. The project combines statistical and artificial intelligence methodologies to uncover hidden cellular histories not observable through conventional tissue analysis, with validation conducted in systems where longitudinal sequencing is feasible to ensure methodological rigor. Deliverables include novel computational tools and validated analytical frameworks that advance understanding of complex biological processes underlying disease mechanisms, with potential applications informing therapeutic strategies and supporting NIGMS's mission to enhance health and reduce disease burden through innovative biomedical research.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $380.4k | 2/26/26 |